chrX-153905518-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_000054.7(AVPR2):​c.26-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,174,932 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000023 ( 0 hom. 8 hem. )

Consequence

AVPR2
NM_000054.7 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.744

Publications

0 publications found
Variant links:
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
AVPR2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nephrogenic syndrome of inappropriate antidiuresis
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-153905518-C-T is Benign according to our data. Variant chrX-153905518-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2972617.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 24 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AVPR2NM_000054.7 linkc.26-14C>T intron_variant Intron 2 of 3 ENST00000646375.2 NP_000045.1 P30518-1
AVPR2NM_001146151.3 linkc.26-14C>T intron_variant Intron 2 of 2 NP_001139623.1 P30518-2
AVPR2NR_027419.2 linkn.465+348C>T intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AVPR2ENST00000646375.2 linkc.26-14C>T intron_variant Intron 2 of 3 NM_000054.7 ENSP00000496396.1 P30518-1
ENSG00000284987ENST00000646191.1 linkn.96+3552G>A intron_variant Intron 1 of 4 ENSP00000493873.1 A0A2R8Y4P6

Frequencies

GnomAD3 genomes
AF:
0.00000888
AC:
1
AN:
112614
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000482
AC:
6
AN:
124442
AF XY:
0.0000742
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000454
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000416
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000204
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000226
AC:
24
AN:
1062318
Hom.:
0
Cov.:
29
AF XY:
0.0000233
AC XY:
8
AN XY:
344026
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25323
American (AMR)
AF:
0.0000326
AC:
1
AN:
30637
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18801
East Asian (EAS)
AF:
0.000143
AC:
4
AN:
28068
South Asian (SAS)
AF:
0.0000197
AC:
1
AN:
50862
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37309
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3225
European-Non Finnish (NFE)
AF:
0.0000206
AC:
17
AN:
823419
Other (OTH)
AF:
0.0000224
AC:
1
AN:
44674
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000888
AC:
1
AN:
112614
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34772
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31029
American (AMR)
AF:
0.00
AC:
0
AN:
10805
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2661
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6241
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53108
Other (OTH)
AF:
0.00
AC:
0
AN:
1516
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Feb 14, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.1
DANN
Benign
0.58
PhyloP100
-0.74
PromoterAI
0.042
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781795563; hg19: chrX-153170972; API